Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
The Journal of Gene Medicine|December 7, 2006
Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicityAnna Kanerva, Mari Raki, Tuuli Ranki, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
International Journal of Cancer|June 16, 2004
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancerGerd J Bauerschmitz, Anna Kanerva, Minghui Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2016
Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive MelanomaMikko Siurala, Riikka Havunen, Dipongkor Saha, et al.
Human Gene Therapy|February 26, 2009
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liverIulia Diaconu, Laura Denby, Sari Pesonen, et al.
Cancer Research|August 3, 2002
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptorsYosef S Haviv, Jerry L Blackwell, Anna Kanerva, et al.
Oncoimmunology|November 3, 2018
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapySadia Zafar, Suvi Sorsa, Mikko Siurala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancerOtto Hemminki, Iulia Diaconu, Vincenzo Cerullo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cellsGerd J Bauerschmitz, Kilian Guse, Anna Kanerva, et al.
Human Gene Therapy|May 18, 2004
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapyMartina Breidenbach, Daniel T Rein, Minghui Wang, et al.
Pageof 28